{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:52:32Z","timestamp":1788346352869,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.gene.2024.148368","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T12:29:11Z","timestamp":1710246551000},"page":"148368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A review of the advances, insights, and prospects of gene therapy for Alzheimer\u2019s disease: A novel target for therapeutic medicine"],"prefix":"10.1016","volume":"912","author":[{"given":"Bahar","family":"Ataei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Hokmabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Asadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohsen","family":"Aghaei Zarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-5778","authenticated-orcid":false,"given":"Sajad","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-4185","authenticated-orcid":false,"given":"Saeid","family":"Bagheri-Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2024.148368_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117996","article-title":"Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions","volume":"256","author":"Abeysinghe","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.22270\/jddt.v9i4.3173","article-title":"A review article on gene therapy","volume":"9","author":"Akki","year":"2019","journal-title":"J. Drug Delivery & Therapeutics"},{"key":"10.1016\/j.gene.2024.148368_b0015","series-title":"Research strategies developed for the treatment of Alzheimer\u2019s disease. reversible and pseudo-irreversible inhibitors of acetylcholinesterase: structure-activity relationships and drug design. InDrug design and discovery in Alzheimer's disease","first-page":"426","author":"Alcolea-Palafox","year":"2014"},{"key":"10.1016\/j.gene.2024.148368_b0020","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11033-018-4499-7","article-title":"Stem cell therapy in Alzheimer\u2019s disease: possible benefits and limiting drawbacks","volume":"46","author":"Alipour","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/hum.2016.017","article-title":"Gene therapy strategies for Alzheimer's disease: an overview","volume":"27","author":"Alves","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11064-020-03162-4","article-title":"Microglia in Alzheimer's disease: the role of stem cell-microglia interaction in brain homeostasis","volume":"46","author":"Bagheri-Mohammadi","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10561-020-09885-6","article-title":"Protective effects of mesenchymal stem cells on ischemic brain injury: therapeutic perspectives of regenerative medicine","volume":"22","author":"Bagheri-Mohammadi","year":"2021","journal-title":"Cell Tissue Bank."},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10561-020-09896-3","article-title":"Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment","volume":"22","author":"Bagheri-Mohammadi","year":"2021","journal-title":"Cell Tissue Bank."},{"issue":"12","key":"10.1016\/j.gene.2024.148368_b0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/00207454.2020.1865953","article-title":"Adult neurogenesis and the molecular signalling pathways in brain: the role of stem cells in adult hippocampal neurogenesis","volume":"132","author":"Bagheri-Mohammadi","year":"2022","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jcp.27182","article-title":"Stem cell-based therapy for Parkinson\u2019s disease with a focus on human endometrium-derived mesenchymal stem cells","volume":"234","author":"Bagheri-Mohammadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.gene.2024.148368_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biologicals.2020.09.004","article-title":"Novel application of adipose-derived mesenchymal stem cells via producing antiangiogenic factor TSP-1 in lung metastatic melanoma animal model","volume":"68","author":"Bagheri-Mohammadi","year":"2020","journal-title":"Biologicals"},{"issue":"11","key":"10.1016\/j.gene.2024.148368_b0060","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s12031-022-02075-x","article-title":"Cinnamaldehyde regulates insulin and Caspase-3 signaling pathways in the sporadic Alzheimer\u2019s disease model: involvement of hippocampal function via IRS-1, akt, and GSK-3\u03b2 phosphorylation","volume":"72","author":"Bagheri-Mohammadi","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.gene.2024.148368_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30414","article-title":"The mitochondrial calcium signaling, regulation, and cellular functions: a novel target for therapeutic medicine in neurological disorders","author":"Bagheri-Mohammadi","year":"2023","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/acn3.755","article-title":"Alternative splicing in a presenilin 2 variant associated with Alzheimer disease","volume":"6","author":"Braggin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.trci.2019.09.011","article-title":"Comparison of cholinesterase inhibitor safety in real-world practice","volume":"5","author":"Carney","year":"2019","journal-title":"Alzheimer's & Dementia: Translational Res. & Clinical Interventions"},{"issue":"8","key":"10.1016\/j.gene.2024.148368_b0085","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0090","doi-asserted-by":"crossref","first-page":"e10367","DOI":"10.1002\/btm2.10367","article-title":"Alzheimer's and Parkinson's disease therapies in the clinic","volume":"8","author":"Chopade","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"5","key":"10.1016\/j.gene.2024.148368_b0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","article-title":"Physical exercise in the prevention and treatment of Alzheimer's disease","volume":"9","author":"De la Rosa","year":"2020","journal-title":"J. Sport Health Sci."},{"key":"10.1016\/j.gene.2024.148368_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/207178","article-title":"Alzheimer's disease clinical and research update for health care practitioners","author":"DeFina","year":"2013","journal-title":"J. Aging Res."},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0409072102","article-title":"Gene delivery of human apolipoprotein E alters brain a\u03b2 burden in a mouse model of Alzheimer's disease","volume":"102","author":"Dodart","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-190507","article-title":"Developing effective Alzheimer\u2019s disease therapies: clinical experience and future directions","volume":"71","author":"Elmaleh","year":"2019","journal-title":"J. Alzheimer's Disease"},{"issue":"9","key":"10.1016\/j.gene.2024.148368_b0115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/mds.21423","article-title":"Gene transfer therapy for neurodegenerative disorders","volume":"22","author":"Feigin","year":"2007","journal-title":"Movement Disorders: Official J. Movement Disorder Society"},{"key":"10.1016\/j.gene.2024.148368_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15781","article-title":"Apolipoprotein E \u03b54 modulates astrocyte neuronal support functions in the presence of amyloid-\u03b2","author":"Fleeman","year":"2023","journal-title":"J. Neurochemistry"},{"key":"10.1016\/j.gene.2024.148368_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-015-1498-9","article-title":"Viral gene transfer of APPs\u03b1 rescues synaptic failure in an Alzheimer\u2019s disease mouse model","volume":"131","author":"Fol","year":"2016","journal-title":"Acta Neuropathological"},{"issue":"4\u20135","key":"10.1016\/j.gene.2024.148368_b0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuropharm.2010.02.010","article-title":"Neurochemical basis for symptomatic treatment of Alzheimer's disease","volume":"59","author":"Francis","year":"2010","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.gene.2024.148368_b0135","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0140","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1038\/s41467-020-18198-x","article-title":"Association of APOE e2 genotype with Alzheimer\u2019s and non-Alzheimer\u2019s neurodegenerative pathologies","volume":"11","author":"Goldberg","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2024.148368_b0145","first-page":"1","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative., 2020 The dynamics of biomarkers across the clinical spectrum of Alzheimer\u2019s disease","volume":"12","author":"Hadjichrysanthou","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0150","first-page":"177","article-title":"Clinical immunotherapy trials in Alzheimer\u2019s disease","volume":"5","author":"Hawkes","year":"2008","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1123\/japa.2014-0180","article-title":"What are the benefits of exercise for Alzheimer\u2019s disease? a systematic review of the past 10 years","volume":"23","author":"Hernandez","year":"2015","journal-title":"J. Aging Phys. Act."},{"issue":"11","key":"10.1016\/j.gene.2024.148368_b0160","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1002\/jcb.27202","article-title":"Stem cell-and gene-based therapies as potential candidates in Alzheimer's therapy","volume":"119","author":"Hosseini","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"212","key":"10.1016\/j.gene.2024.148368_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1566523220999200716111502","article-title":"Gene therapy, a novel therapeutic tool for neurological disorders: current progress, challenges and future prospective","volume":"20","author":"Iqubal","year":"2020","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.gene.2024.148368_b0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40266-017-0499-x","article-title":"Recent progress in the pharmacotherapy of Alzheimer\u2019s disease","volume":"34","author":"Khoury","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.gene.2024.148368_b0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2020.00754","article-title":"The important interface between apolipoprotein E and neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Kloske","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.gene.2024.148368_b0190","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201887","article-title":"Apolipoprotein E intersects with amyloid-\u03b2 within neurons","volume":"6","author":"Konings","year":"2023","journal-title":"Life Sci. Alliance"},{"issue":"10","key":"10.1016\/j.gene.2024.148368_b0195","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.241687","article-title":"Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia","volume":"133","author":"Kopach","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2024.148368_b0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","article-title":"Apolipoprotein e and alzheimer's disease: findings, hypotheses, and potential mechanisms","volume":"17","author":"Koutsodendris","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12798","article-title":"Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F)","volume":"53","author":"Li","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2024.148368_b0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.gene.2024.148368_b0225","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","article-title":"Stem cell therapy for Alzheimer's disease","volume":"12","author":"Liu","year":"2020","journal-title":"World Journal of Stem Cells"},{"key":"10.1016\/j.gene.2024.148368_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2023.01.022","article-title":"Cross Interactions between apolipoprotein E and amyloid proteins in neurodegenerative diseases","author":"Loch","year":"2023","journal-title":"Computational and Structural Biotechnol. J."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.12759","article-title":"Targeting Alzheimer's disease with gene and cell therapies","volume":"284","author":"Loera-Valencia","year":"2018","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1566523222666220328142427","article-title":"Gene therapy, a potential therapeutic tool for neurological and neuropsychiatric Disorders: applications, challenges and future perspective","volume":"23","author":"Mani","year":"2023","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.gene.2024.148368_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/728983","article-title":"New acetylcholinesterase inhibitors for Alzheimer's disease","author":"Mehta","year":"2012","journal-title":"Int. J. Alzheimer\u2019s disease"},{"issue":"18","key":"10.1016\/j.gene.2024.148368_b0250","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1523\/JNEUROSCI.0577-07.2007","article-title":"The influence of expected value on saccadic preparation","volume":"27","author":"Milstein","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0255","first-page":"127","article-title":"Human gene therapy: a brief overview of the genetic revolution","volume":"61","author":"Misra","year":"2013","journal-title":"J. Assoc Physicians India"},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1566523218666180302163029","article-title":"Dysfunction in brain-derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson's and Alzheimer's diseases","volume":"18","author":"Mohammadi","year":"2018","journal-title":"Curr. Gene Ther."},{"issue":"7573","key":"10.1016\/j.gene.2024.148368_b0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0270","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","article-title":"Gene therapy in Alzheimer\u2019s disease\u2013potential for disease modification","volume":"14","author":"Nilsson","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0275","first-page":"1","article-title":"Adult hippocampal neurogenesis and alzheimer's disease: novel application of mesenchymal stem cells and their role in hippocampal neurogenesis","volume":"10","author":"Noureddini","year":"2021","journal-title":"Int. J. Molecular and Cellular Medicine"},{"issue":"8","key":"10.1016\/j.gene.2024.148368_b0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.molmed.2015.06.001","article-title":"Gene therapy for neurodegenerative diseases","volume":"21","author":"O\u2019Connor","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.gene.2024.148368_b0285","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","article-title":"PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer's disease","volume":"9","author":"Oksanen","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"10","key":"10.1016\/j.gene.2024.148368_b0290","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","article-title":"Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood","volume":"26","author":"Ou","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.gene.2024.148368_b0295","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR\u2013Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.gene.2024.148368_b0300","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/ijms21093158","article-title":"Utility of animal models to understand human Alzheimer\u2019s disease, using the mastermind research approach to avoid unnecessary further sacrifices of animals","volume":"21","author":"Qin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh., 10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer's disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.gene.2024.148368_b0310","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","article-title":"Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease","volume":"327","author":"Santos","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.gene.2024.148368_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120375","article-title":"Gene therapy: comprehensive overview and therapeutic applications","author":"Sayed","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.gene.2024.148368_b0320","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn1531","article-title":"Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model","volume":"8","author":"Singer","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"7503","key":"10.1016\/j.gene.2024.148368_b0325","first-page":"26","article-title":"The forgetting gene: for decades, most researchers ignored the leading genetic risk factor for Alzheimer's disease","volume":"510","author":"Spinney","year":"2014","journal-title":"That Is Set to Change. Nature"},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0330","article-title":"FDA approves new drug to treat dementia","volume":"41","author":"Spray","year":"2015","journal-title":"J. Gerontol. Nurs."},{"issue":"3","key":"10.1016\/j.gene.2024.148368_b0335","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/humc.2016.056","article-title":"Optimizing transgene configuration and protein fusions to maximize dopamine production for the gene therapy of Parkinson's disease","volume":"27","author":"Stewart","year":"2016","journal-title":"Hum. Gene Ther. Clin. Dev."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene therapy for neurodegenerative diseases","volume":"16","author":"Sudhakar","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.gene.2024.148368_b0345","series-title":"Martindale: the complete drug reference","author":"Sweetman","year":"2009"},{"key":"10.1016\/j.gene.2024.148368_b0350","article-title":"A review on advances of treatment modalities for Alzheimer's disease","volume":"276","author":"Thoe","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.gene.2024.148368_b0355","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v8i12.2271","article-title":"Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: past, present, and potential future","volume":"8","author":"Truong","year":"2020","journal-title":"Medical Research Archives"},{"issue":"5","key":"10.1016\/j.gene.2024.148368_b0360","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.gene.2024.148368_b0365","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1582-4934.2010.01148.x","article-title":"miRNA profiling along tumour progression in ovarian carcinoma","volume":"15","author":"Vaksman","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2024.148368_b0370","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14283\/jpad.2019.3","article-title":"Implications for BACE1 inhibitor clinical trials: adult conditional BACE1 knockout mice exhibit axonal organization defects in the hippocampus","volume":"6","author":"Vassar","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.gene.2024.148368_b0375","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.biochem.74.050304.091637","article-title":"Gene therapy: twenty-first century medicine","volume":"74","author":"Verma","year":"2005","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.gene.2024.148368_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting apolipoprotein E function in Alzheimer\u2019s disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0385","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.gene.2024.148368_b0390","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.gene.2024.148368_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","author":"Yang","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.gene.2024.148368_b0400","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Central Nervous System Disease"},{"issue":"15","key":"10.1016\/j.gene.2024.148368_b0405","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms22158208","article-title":"Novel therapeutic approaches for Alzheimer\u2019s disease: an updated review","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.gene.2024.148368_b0410","first-page":"398","article-title":"Gene therapy strategies targeting aging-related diseases","volume":"14","author":"Yu","year":"2023","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.gene.2024.148368_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13619-022-00128-5","article-title":"The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's disease","volume":"11","author":"Yue","year":"2022","journal-title":"Cell Regeneration"},{"key":"10.1016\/j.gene.2024.148368_b0420","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","article-title":"Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models","volume":"44","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192400249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192400249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T17:12:28Z","timestamp":1759857148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811192400249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":84,"alternative-id":["S037811192400249X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2024.148368","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the advances, insights, and prospects of gene therapy for Alzheimer\u2019s disease: A novel target for therapeutic medicine","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2024.148368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148368"}}